Tadalafil Devatis 20 mg, Filmtabletten - 4 Swissmedic Key 70000005 Registration Holder Devatis AG Name Tadalafil Devatis 20 mg, Filmtabletten Date of registration 19.01.2026 Introduction of Sequence 19.01.2026 ATC-Classification Tadalafil (G04BE08) Revision date WHO WHO-DDD Valid until 18.01.2031 Index Therapeuticus (BSV) Show package size 4 Index Therapeuticus (Swissmedic) 05.99. Description Swissmedic categorie. B SL Eintrag No Indication Information for professionals IP Consumer information CI Deductible k.A. Feedback FB GTIN 7680700000055 Medication Code Synthetika Pharmacode Disponibility
Composition tadalafilum 20 mg, lactosum monohydricum 249 mg, carmellosum natricum conexum, natrii laurilsulfas, hydroxypropylcellulosum, cellulosum microcristallinum, magnesii stearas, Überzug: lactosum monohydricum 3.6 mg, hypromellosum, E 171, E 172 (flavum), triacetinum, talcum, pro compresso obducto corresp. natrium 0.71 mg. Packungsbestandteile Galenic Form Coated tablets Active Agent Dose Tadalafilum 20 mg
Inactive agents Dose additional_information (Flavum) Carmellosum Natricum Conexum Cellulosum Microcristallinum E 171 color. E 172 color. Hydroxypropylcellulosum Hypromellosum Lactose Monohydrate 3.6 mg Überzug Magnesii Stearas Natrii Laurilsulfas Pro Compresso Obducto Talcum Triacetinum
Source Data was imported : 04.02.2026
Swissmedic Registration :
Sequence :
Product name :
Registration owner: :
Product group :
Index Therapeuticus (BSV) :
Medication Code :
Date of registration :
Valid until :
Package number :
Show package size :
Commercial Form/Unit :
Swissmedic categorie. :
Active Agents :
Composition :
